Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.37Price to Book
VS
Market
Sector
Industry
History
$ 2.7Close
$ 2.36 - $ 4.04 52-Week Range
Ticker Information
Ticker
KPRXCompany Name
KIORA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKIORA PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPRX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 22.13M | $ 8.1M | 0.37 |
| 3/31/2025 | $ 23.7M | $ 9.89M | 0.42 |
| 12/31/2024 | $ 25.76M | $ 9.12M | 0.35 |
| 9/30/2024 | $ 30.03M | $ 10.58M | 0.35 |
| 6/30/2024 | $ 33.1M | $ 9.95M | 0.3 |
| 3/31/2024 | $ 34.9M | $ 12.77M | 0.37 |
| 12/31/2023 | $ 6.11M | $ 15.26M | 2.5 |
| 9/30/2023 | $ 8.1M | $ 4.99M | 0.62 |
| 6/30/2023 | $ 13.64M | $ 4.06M | 0.3 |
| 3/31/2023 | $ 10.16M | $ 5.12M | 0.5 |
Key Performance Insights, Last 5 Years
- KIORA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 2.56.
- Over the past 5 years, KIORA PHARMACEUTICALS INC's average P/B has been 1.12.
- The median P/B for KIORA PHARMACEUTICALS INC during this period was 0.58
- KIORA PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 5.14.
- The lowest P/B recorded by KIORA PHARMACEUTICALS INC in the same timeframe 0.3
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for KIORA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 15.27M ] / Equity [ $ 5.96M ]
(=) P/B [ 2.56 ] KPRX - Price to Book, Last 5 years
0.3
Minimum
Jun 30, 2023
5.14
Maximum
Dec 31, 2020
1.12
Average
0.58
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |